Literature DB >> 17909055

Tumor necrosis factor alpha mediates homogeneous distribution of liposomes in murine melanoma that contributes to a better tumor response.

Ann L B Seynhaeve1, Saske Hoving, Debby Schipper, Cindy E Vermeulen, Gisela aan de Wiel-Ambagtsheer, Sandra T van Tiel, Alexander M M Eggermont, Timo L M Ten Hagen.   

Abstract

Successful treatment of solid tumors with chemotherapeutics requires that adequate levels reach the tumor cells. Tumor vascular normalization has been proposed to enhance drug delivery and improve tumor response to chemotherapy. Differently, augmenting leakage of the tumor-associated vasculature, and as such enhance vascular abnormality, may improve tumor response as well. In the present study, we show that addition of low-dose tumor necrosis factor alpha (TNF) to systemic injections with pegylated long circulating liposomes augmented the tumor accumulation of these liposomes 5- to 6-fold, which strongly correlated with enhanced tumor response. Using intravital microscopy, we could study the liposomal distribution inside the tumor in more detail. Especially 100 nm liposomes effectively extravasate in the surrounding tumor tissue in the presence of TNF and this occurred without any effect on tumor vascular density, branching, and diameter. Next to that, we observed in living animals that tumor cells take up the liposomes intact, followed by intracellular degradation. To our knowledge, this is an unprecedented observation. Taken together, TNF renders more tumor vessels permeable, leading to a more homogeneous distribution of the liposomes throughout the tumor, which is crucial for an optimal tumor response. We conclude that delivery of nanoparticulate drug formulations to solid tumor benefits from augmenting the vascular leakage through vascular manipulation with vasoactive drugs like TNF.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17909055     DOI: 10.1158/0008-5472.CAN-07-1599

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  43 in total

1.  Short-chain glycoceramides promote intracellular mitoxantrone delivery from novel nanoliposomes into breast cancer cells.

Authors:  Lília R Cordeiro Pedrosa; Timo L M Ten Hagen; Regine Süss; Albert van Hell; Alexander M M Eggermont; Marcel Verheij; Gerben A Koning
Journal:  Pharm Res       Date:  2014-10-16       Impact factor: 4.200

Review 2.  Strategies for improving the intratumoral distribution of liposomal drugs in cancer therapy.

Authors:  Beth Goins; William T Phillips; Ande Bao
Journal:  Expert Opin Drug Deliv       Date:  2016-04-04       Impact factor: 6.648

3.  Systemic TNFα gene therapy synergizes with liposomal doxorubicine in the treatment of metastatic cancer.

Authors:  Baowei Su; Arzu Cengizeroglu; Katarina Farkasova; Joana R Viola; Martina Anton; Joachim W Ellwart; Rudolf Haase; Ernst Wagner; Manfred Ogris
Journal:  Mol Ther       Date:  2012-11-13       Impact factor: 11.454

Review 4.  Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles.

Authors:  Mark J Ernsting; Mami Murakami; Aniruddha Roy; Shyh-Dar Li
Journal:  J Control Release       Date:  2013-09-25       Impact factor: 9.776

5.  Challenges associated with Penetration of Nanoparticles across Cell and Tissue Barriers: A Review of Current Status and Future Prospects.

Authors:  Sutapa Barua; Samir Mitragotri
Journal:  Nano Today       Date:  2014-04-01       Impact factor: 20.722

6.  Antitumor and immunostimulatory activities of a genotype V recombinant attenuated veterinary Newcastle disease virus vaccine.

Authors:  Oscar Antonio Ortega-Rivera; J Luis Quintanar; Susana Del Toro-Arreola; Ángel G Alpuche-Solis; Mayra J Esparza-Araiza; Eva Salinas
Journal:  Oncol Lett       Date:  2017-11-09       Impact factor: 2.967

Review 7.  Nanoplatforms for Targeted Stimuli-Responsive Drug Delivery: A Review of Platform Materials and Stimuli-Responsive Release and Targeting Mechanisms.

Authors:  Yuzhe Sun; Edward Davis
Journal:  Nanomaterials (Basel)       Date:  2021-03-16       Impact factor: 5.076

Review 8.  Thermosensitive liposomes for localized delivery and triggered release of chemotherapy.

Authors:  Terence Ta; Tyrone M Porter
Journal:  J Control Release       Date:  2013-04-11       Impact factor: 9.776

Review 9.  Nanogels: An overview of properties, biomedical applications and obstacles to clinical translation.

Authors:  Kruti S Soni; Swapnil S Desale; Tatiana K Bronich
Journal:  J Control Release       Date:  2015-11-10       Impact factor: 9.776

10.  Hyperthermia and thermosensitive liposomes for improved delivery of chemotherapeutic drugs to solid tumors.

Authors:  Gerben A Koning; Alexander M M Eggermont; Lars H Lindner; Timo L M ten Hagen
Journal:  Pharm Res       Date:  2010-04-28       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.